Ann: Stable Cell Line for Production of PAT-DX3 Established, page-14

Good to see progress with PAT-DX3


Had the company email me the top 20 a few weeks ago and our trio of smart money Mason Stevens holding over 5% , Macquarie Bank holding just under 5% and Kerry Stokes holding around 40m shares. They have all paid on average higher than the current price and like me we are all staying till the technology is commercialised.


https://au.linkedin.com/company/patrys-limited

Interesting comment last week on a post on Linkedin

"This mounts an interesting case for novel applications of our deoxymab technology at Patrys Limited. One of the major challenges for gene editing technologies is getting the editing cassettes into the cell nucleus – a task which has, to date, only been achieved by viral vectors. Given our deoxymabs are able to cross the cell membrane and the nuclear membrane, and deliver payloads inside cells, the possibilities could be endless."